Results 101 to 110 of about 1,197 (161)

Determination of correlates of protection against tuberculosis in nonhuman primate models [PDF]

, 2017
Tuberculosis (TB) is one of the greatest global health challenges society faces. BCG, the only licensed vaccine for TB, has profoundly variable efficacy and does not prevent the spread of TB.
DiFazio, Robert M.
core  

A protective, single-visit TB vaccination regimen by co-administration of a subunit vaccine with BCG. [PDF]

NPJ Vaccines, 2023
Dijkman K, Lindenstrøm T, Rosenkrands I, Søe R, Woodworth JS, Lindestam Arlehamn CS, Mortensen R.   +6 more
europepmc   +1 more source

CAF01 for systemic immunization

Vial with ready to use adjuvant for bed-side-mix with antigen from ...
openaire   +1 more source

IL-4 and helminth infection downregulate MINCLE-dependent macrophage response to mycobacteria and Th17 adjuvanticity. [PDF]

Elife, 2023
Schick J, Altunay M, Lacorcia M, Marschner N, Westermann S, Schluckebier J, Schubart C, Bodendorfer B, Christensen D, Alexander C, Wirtz S, Voehringer D, da Costa CP, Lang R.   +13 more
europepmc   +1 more source

Genital Infiltrations of CD4⁺ and CD8⁺ T Lymphocytes, IgA⁺ and IgG⁺ Plasma Cells and Intra-Mucosal Lymphoid Follicles Associate With Protection Against Genital Chlamydia trachomatis Infection in Minipigs Intramuscularly Immunized With UV-Inactivated Bacteria Adjuvanted With CAF01

, 2019
The development of a vaccine against genital chlamydia in women is advancing, and the evaluation of in situ immune responses following vaccination and challenge infections is crucial for development of a safe and protective vaccine. This study employs the sexually mature minipig model to characterize the genital in situ immune response to Chlamydia ...
Erneholm, Karin, Lorenzen, Emma, Boje, Sarah, Olsen, Anja Weinreich, Jungersen, Gregers, Jensen, Henrik E., Cassidy, Joseph P., Andersen, Peter, Agerholm, Jørgen S., Follmann, Frank   +9 more
openaire   +1 more source

Cellular and antibody response in GMZ2-vaccinated Gabonese volunteers in a controlled human malaria infection trial. [PDF]

Malar J, 2022
Nouatin O, Ibáñez J, Fendel R, Ngoa UA, Lorenz FR, Dejon-Agobé JC, Edoa JR, Flügge J, Brückner S, Esen M, Theisen M, Hoffman SL, Moutairou K, Luty AJF, Lell B, Kremsner PG, Adegnika AA, Mordmüller B.   +17 more
europepmc   +1 more source

Immunization of chickens with a recombinant Ascaridia galli protein results in parasite-specific IgG with no protective effect against infection [PDF]

, 2012
Dalgaard, T., Fink, Dorte Rosenbek, Jungersen, Gregers, Juul-Madsen, H. R., Norup, L. R., Schou, T. W.   +5 more
core  

Intranasal vaccination with killed Leishmania amazonensis promastigotes antigen (LaAg) associated with CAF01 adjuvant induces partial protection in BALB/c mice challenged with Leishmania (infantum) chagasi - CORRIGENDUM [PDF]

Parasitology, 2015
JANINE MIRANDA LEAL, MARCELLE MOSQUINI, LUCIANA POLACO COVRE, NATALY PESCINALLI STAGMILLER, RODRIGO RIBEIRO RODRIGUES, DENNIS CHRISTENSEN, HERBET LEONEL DE MATTOS GUEDES, BARTIRA ROSSI-BERGMANN, DANIEL CLÁUDIO DE OLIVIERA GOMES   +8 more
openaire   +1 more source

Targeting myoferlin in ER/Golgi vesicle trafficking reprograms pancreatic cancer-associated fibroblasts. [PDF]

EMBO J
Peiffer R, Laverdeur E, Gaigneaux A, Boumahd Y, Gullo C, Rademaker G, Crake R, Lavergne A, Maloujahmoum N, Agirman F, Herfs M, Masamune A, Letellier E, Bellahcène A, Peulen O.   +14 more
europepmc   +1 more source

Distinct humoral responses induced by heterologous versus homologous prime-boost immunization strategies in early life. [PDF]

Front Immunol
Foroutan Pajoohian P, Aradottir Pind AA, Molina Estupiñan JL, Christensen D, Pedersen GK, Olafsdottir TA, Jonsdottir I, Bjarnarson SP.   +7 more
europepmc   +1 more source